- Undergraduate
Bachelor's Degrees
Bachelor of ArtsBachelor of EngineeringDual-Degree ProgramUndergraduate AdmissionsUndergraduate Experience
- Graduate
Graduate Experience
- Research
- Entrepreneurship
- Community
- About
-
Search
News
Nov 19, 2024 | Magnuson Center
Dartmouth Medtech Company Turns to Equity Crowdfunding
Lodestone Biomedical, founded by Professor of Engineering Sol Diamond, aims to raise $1.2M through investments of as small as just over $100 over the next three months.News
Nov 13, 2024
Dartmouth Engineering Student Wins Ivy Collective Symposium's Three-Minute Thesis Competition
Nov 01, 2024
Dartmouth Student Team Creates Award-Winning Tool for More Bike-Walk-Friendly Town Planning
In the News
TIME
Considering the Case for Hydrogen Home Heating
Dean Alexis Abramson is author of an opinion piece about the potential of using hydrogen for heating buildings. "The remarkable rise in electrification in recent years is a testament to America's commitment to the clean energy transition. Electric heat pumps powered by clean electricity will play a significant role in decarbonization of the grid, but they are not, alone, a viable solution everywhere," Abramson said.
Nov 08, 2024
Financial Times
Biden's Climate Legacy in Focus as US Prepares for Trump's Return
Dean Alexis Abramson is quoted in an article examining what Trump's presidential victory means for energy transition and the response to climate change. "Few Americans know that the Inflation Reduction Act is the most significant climate policy the US has ever seen," said Abramson. "Remarkably, our country passed this legislation at a time when political polarization has deepened."
Nov 06, 2024
S&P Global
NH governor candidates differ on offshore wind, net metering, nuclear
Dean Alexis Abramson is quoted in a story about debate over NH's energy policy: "There is a strong correlation between net metering and the availability of net metering for consumers and the adoption of renewables, mostly solar," she says.
Oct 21, 2024
Valley News
Dartmouth Labs Get Federal Grants for Vaccine Research
Two Dartmouth research teams—one led by David Leib, chair and professor of microbiology and immunology, and the other led by Margaret Ackerman, a professor of engineering—are receiving funding from the Biden-Harris Administration's Advanced Research Projects Agency for Health to spur innovations in pandemic preparedness and vaccine generation.
Oct 14, 2024
Research Quick Takes
Silicon for the Quantum Defect Era
Research associates Yihuang Xiong and Jiongzhi Zheng, PhD student Shay McBride, and Professor Geoffroy Hautier are co-authors of "Computationally Driven Discovery of T Center-like Quantum Defects in Silicon" published in Journal of the American Chemical Society. "Finding new 'quantum defects' facilitates bringing quantum technologies to real world scalable technologies." says Hautier. Adds Xiong, "Our study identifies several silicon defects that were overlooked before the quantum defect era and proposes high-yield synthesis routes."
On the Future of Flexible Electronics
Professor Will Scheideler authored "Nimble native oxides: Printing circuits from the skin of liquid metal," published in Matter, which focuses on new two-dimensional metal oxides that are thin, transparent, and flexible. "This preview highlights the opportunities for new applications of flexible and printed electronics and discusses a few of the most important challenges for this emerging research field," says Scheideler.
BMES Annual Meeting
At the 2024 Biomedical Engineering Society (BMES) Annual Meeting in Baltimore, MS student Anisia Tiplea '24 presented her senior honors thesis, and Hixon Lab gave an invited talk on their bone regeneration work supported by the Dartmouth Innovations Accelerator for Cancer.
INFORMS MIF Best Paper Award
Professor Wesley Marrero received the INFORMS MIF Best Paper Award as co-author of, "Interpretable Policies and the Price of Interpretability in Hypertension Treatment Planning" published in Manufacturing & Service Operations Management. The paper uses optimization to design clinically intuitive hypertension treatment protocols that greatly outperform clinical guidelines.